260 related articles for article (PubMed ID: 24362533)
1. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
Lai AY; Fatemi M; Dhasarathy A; Malone C; Sobol SE; Geigerman C; Jaye DL; Mav D; Shah R; Li L; Wade PA
J Exp Med; 2010 Aug; 207(9):1939-50. PubMed ID: 20733034
[TBL] [Abstract][Full Text] [Related]
3. Role of CTCF protein in regulating FMR1 locus transcription.
Lanni S; Goracci M; Borrelli L; Mancano G; Chiurazzi P; Moscato U; Ferrè F; Helmer-Citterich M; Tabolacci E; Neri G
PLoS Genet; 2013; 9(7):e1003601. PubMed ID: 23874213
[TBL] [Abstract][Full Text] [Related]
4. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
[TBL] [Abstract][Full Text] [Related]
5. BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.
Ramachandrareddy H; Bouska A; Shen Y; Ji M; Rizzino A; Chan WC; McKeithan TW
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11930-5. PubMed ID: 20547840
[TBL] [Abstract][Full Text] [Related]
6. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.
Pasqualucci L; Migliazza A; Basso K; Houldsworth J; Chaganti RS; Dalla-Favera R
Blood; 2003 Apr; 101(8):2914-23. PubMed ID: 12515714
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus.
Papadopoulou V; Postigo A; Sánchez-Tilló E; Porter AC; Wagner SD
Biochem J; 2010 Apr; 427(3):541-50. PubMed ID: 20175752
[TBL] [Abstract][Full Text] [Related]
10. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
11. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
12. CTCF induces histone variant incorporation, erases the H3K27me3 histone mark and opens chromatin.
Weth O; Paprotka C; Günther K; Schulte A; Baierl M; Leers J; Galjart N; Renkawitz R
Nucleic Acids Res; 2014 Oct; 42(19):11941-51. PubMed ID: 25294833
[TBL] [Abstract][Full Text] [Related]
13. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
14. The role of BCL6 in lymphomas and routes to therapy.
Wagner SD; Ahearne M; Ko Ferrigno P
Br J Haematol; 2011 Jan; 152(1):3-12. PubMed ID: 21083654
[TBL] [Abstract][Full Text] [Related]
15. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
Baron BW; Baron RM; Baron JM
Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
[TBL] [Abstract][Full Text] [Related]
16. CTCF binding site classes exhibit distinct evolutionary, genomic, epigenomic and transcriptomic features.
Essien K; Vigneau S; Apreleva S; Singh LN; Bartolomei MS; Hannenhalli S
Genome Biol; 2009; 10(11):R131. PubMed ID: 19922652
[TBL] [Abstract][Full Text] [Related]
17. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation.
Chen W; Iida S; Louie DC; Dalla-Favera R; Chaganti RS
Blood; 1998 Jan; 91(2):603-7. PubMed ID: 9427715
[TBL] [Abstract][Full Text] [Related]
18. Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
Chang JW; Hsu HS; Ni HJ; Chuang CT; Hsiung CH; Huang TH; Wang YC
PLoS One; 2010 Sep; 5(9):e12847. PubMed ID: 20877461
[TBL] [Abstract][Full Text] [Related]
19. Disruption of genomic neighbourhood at the imprinted IGF2-H19 locus in Beckwith-Wiedemann syndrome and Silver-Russell syndrome.
Nativio R; Sparago A; Ito Y; Weksberg R; Riccio A; Murrell A
Hum Mol Genet; 2011 Apr; 20(7):1363-74. PubMed ID: 21282187
[TBL] [Abstract][Full Text] [Related]
20. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.
Pero R; Palmieri D; Angrisano T; Valentino T; Federico A; Franco R; Lembo F; Klein-Szanto AJ; Del Vecchio L; Montanaro D; Keller S; Arra C; Papadopoulou V; Wagner SD; Croce CM; Fusco A; Chiariotti L; Fedele M
J Biol Chem; 2012 May; 287(22):18308-17. PubMed ID: 22493480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]